Angeion gets CE marking for Sentinel implantable cardioverter defibrillators (ICD):
This article was originally published in Clinica
Executive Summary
Angeion has received European approval to affix CE marking to its Sentinel 2011 and 2012 implantable cardioverter defibrillators (ICD). Last month, Angeion based in Minneapolis, Minnesota, received FDA approval to expand US clinical trials of its Sentinel 2000 and 2010 ICDs adding Models 2011 and 2012.